In this Diabetes Q&A, Laura Hollar, MD, and Kim A. Carmichael, MD, discuss the advantages and use of ultralong-acting and ultrafast-acting insulins for patients with diabetes.
A 36-year-old man presented to the clinic for the evaluation of a new growth under his right arm. He stated that the growth had begun 1 to 2 months prior and had progressively increased in size.